2[1]Ross R. Atherosclerosis-an inflammatory disease [ J ]. N Egl J Med, 1999,340(2):115-126.
3[3]Rahman I, MacNee W. Role of transcription factor in inflammatory lung disease. Thorax, 1998,53: 601-612.
4[4]Weiss D, Kools J J, Taylor WR. Angiotensin Ⅱ -induced hypertension accelerates the development of atherosclerosis in apoEdeficient mice. Circulation, 2001,103:448-454.
5[5]Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol, 1994,12: 141-179.
6[6]Thanos D, Maniatis T. NF-κB: a lesson in family values [J].Cell, 1995,80: 529-532.
7[7]Baeuerle PA,Baltimore D. IκB:a specific inhibitor of the NF-κB transcription factor [J]. Science, 1988,242: 540-546.
8[8]Baeuerle PA, Baltimore D. NF-κB: ten years after [J ]. Cell,1996,87: 13-30.
9[9]Brand K, Page S, Rogler G, et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996,97:1715-1722.
10[10]Ritchie ME. Nuclear factor-κB selectively and markedly activated in humans with unstable angina pectoris[J ]. Circulation,1998,98:1707-1713.
